Showing results (2001-2010 of 2,093) with videos related to
Sort By:
Pageof 210
Emergency Medicine Australasia : EMA|July 13, 2026
Caregiver and Care Recipient Perspectives on Paediatric ED Mental Health Presentations: A Qualitative StudyManissa Sufian, Yao Xu, Marietta John-White, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2020
Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-AnalysisVivian K Kawai, Mingjian Shi, Qiping Feng, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 2, 2024
Research themes and key data points for child and adolescent emergency department mental health presentations: A national Delphi studyMarietta R John-White, Edmund Proper, Frank Muscara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2003
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trialJoseph I Clark, Michael B Atkins, Walter J Urba, et al.Journal of Medical Internet Research|January 8, 2026
A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing StudyEcho L Warner, Alishia Kinsey, Barbara J Walkosz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder CancerChristophe Massard, Michael S Gordon, Sunil Sharma, et al.AIDS Care|December 3, 2016
Co-calibration of two self-reported measures of adherence to antiretroviral therapyRobin M Nance, J A Chris Delaney, Carol E Golin, et al.Journal of Lipid Research|April 9, 2014
Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing ProjectDaniel Seung Kim, David R Crosslin, Paul L Auer, et al.Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.Pageof 210